Supplement industry news and updates – March 2024

FDA releases guidance for NDI notification procedures –  article

The Food and Drug Administration (FDA) unveiled final guidance around procedures and timeframes for new dietary ingredient notifications (NDINs). The new guidance covers issues like who must submit an ingredient notification, how it’s done and details about the process. Check in here for details and industry reaction.

Stranger than fiction: Mercola’s psychic shakeup –  article

Dr. Joseph Mercola, supplement company founder with over two million social media followers and 1,400 products selling online and in stores like Kroger, continues to attract attention after firing top executives earlier this year upon his alleged psychic’s advice. Learn what Natural Products Insider discovered the anti-vaccine influencer foresees next for his business and the planet here.

Severely underpowered: Creatine gummies –  article

Five of the 12 brands of creatine gummies supplement manufacturer NOW tested failed to meet label claims. Find out what the tests revealed about degradation concerns and about what NOW’s struggle to find third-party labs to test the gummies means in broader terms considering the massive popularity of the chewy delivery format. Read more here.

Why Amazon’s absence from trade groups is problematic –  article

Learn how the lack of participation by the largest retailer of dietary supplements in industry trade groups is “a problem for everybody,” according to Dan Fabricant, Ph.D., CEO and president of Natural Products Association. Some associations, however, report progress and renewed engagement from the tech giant. Read more here.

9 out of 10 Amazon galantamine memory “supplements” failed to meet label claim –  article

In research published in the journal JAMA Network that called for stronger FDA enforcement mechanisms, industry critic Pieter Cohen, M.D. found that some of the galantamine products marketed as memory supplements and sold for Alzheimer’s care are vastly understrength. The Council for Responsible Nutrition noted that galantamine, an FDA-approved drug, “is not and never has been a legal supplement ingredient.” Read more here.